Nu Skin Enterprises, Inc. (NYSE:NUS) Chairman Steven Lund Sells 17,129 Shares

Nu Skin Enterprises, Inc. (NYSE:NUSGet Rating) Chairman Steven Lund sold 17,129 shares of the stock in a transaction that occurred on Thursday, June 23rd. The stock was sold at an average price of $45.18, for a total value of $773,888.22. Following the completion of the transaction, the chairman now directly owns 20,800 shares of the company’s stock, valued at approximately $939,744. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Steven Lund also recently made the following trade(s):

  • On Tuesday, June 21st, Steven Lund sold 6,426 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $45.02, for a total value of $289,298.52.
  • On Friday, June 17th, Steven Lund sold 900 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $45.01, for a total value of $40,509.00.
  • On Wednesday, June 15th, Steven Lund sold 395 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $45.00, for a total value of $17,775.00.
  • On Monday, June 13th, Steven Lund sold 51,300 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $43.83, for a total value of $2,248,479.00.
  • On Wednesday, May 18th, Steven Lund sold 925 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $46.07, for a total value of $42,614.75.
  • On Monday, May 16th, Steven Lund sold 21,200 shares of Nu Skin Enterprises stock. The stock was sold at an average price of $45.25, for a total value of $959,300.00.

NYSE NUS traded up $0.84 on Thursday, hitting $45.55. 311,809 shares of the company traded hands, compared to its average volume of 665,974. The company has a market capitalization of $2.29 billion, a price-to-earnings ratio of 16.56 and a beta of 1.23. The company has a current ratio of 1.72, a quick ratio of 0.95 and a debt-to-equity ratio of 0.28. The business’s 50 day moving average price is $45.47 and its 200-day moving average price is $48.05. Nu Skin Enterprises, Inc. has a 52-week low of $39.40 and a 52-week high of $58.97.

Nu Skin Enterprises (NYSE:NUSGet Rating) last released its earnings results on Wednesday, May 4th. The company reported $0.76 earnings per share for the quarter, beating the consensus estimate of $0.73 by $0.03. The company had revenue of $604.90 million for the quarter, compared to the consensus estimate of $579.70 million. Nu Skin Enterprises had a return on equity of 22.05% and a net margin of 5.28%. Nu Skin Enterprises’s quarterly revenue was down 10.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 earnings per share. As a group, sell-side analysts predict that Nu Skin Enterprises, Inc. will post 3.8 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 8th. Investors of record on Friday, May 27th were given a dividend of $0.385 per share. The ex-dividend date of this dividend was Thursday, May 26th. This represents a $1.54 annualized dividend and a yield of 3.38%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 57.04%.

A number of equities analysts have recently issued reports on NUS shares. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Wednesday. TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a research note on Tuesday, June 7th. Two equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $61.50.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. State Street Corp raised its holdings in Nu Skin Enterprises by 317.6% during the first quarter. State Street Corp now owns 6,520,579 shares of the company’s stock valued at $312,205,000 after acquiring an additional 4,959,089 shares during the period. Millennium Management LLC raised its holdings in Nu Skin Enterprises by 1,050.2% during the fourth quarter. Millennium Management LLC now owns 703,938 shares of the company’s stock valued at $35,725,000 after acquiring an additional 642,738 shares during the period. Cooper Creek Partners Management LLC bought a new stake in Nu Skin Enterprises during the fourth quarter valued at about $23,609,000. Invesco Ltd. raised its holdings in Nu Skin Enterprises by 113.4% during the first quarter. Invesco Ltd. now owns 539,301 shares of the company’s stock valued at $25,821,000 after acquiring an additional 286,628 shares during the period. Finally, ProShare Advisors LLC raised its holdings in Nu Skin Enterprises by 30.8% during the fourth quarter. ProShare Advisors LLC now owns 736,731 shares of the company’s stock valued at $37,389,000 after acquiring an additional 173,643 shares during the period. Institutional investors own 93.79% of the company’s stock.

About Nu Skin Enterprises (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

See Also

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.